D-DIMER DYNAMICS AND INFLAMMATION PARAMETERS IN THE FIRST DAYS OF HOSPITALIZATION IN PATIENTS WITH COVID-19.

[1]

S. Chowdhury Dhar and A. Oommen Mary, "Epidemiology of COVID-19," Journal of Digestive Endoscopy., pp. 3-7, 11 March 2020.

[2]

M. Jahangir Asadullah, A. Muheem and M. Rizvi Fatima, "Coronavirus (COVID-19): History, Current Knowledge and Pipeline Medications," International Journal of Pharmaceutics & Pharmacology, vol. 4, no. 1, pp. 1-9, 31 March 2020.

[3]

J. Medicine, "Youtube," 8 April 2020. [Online]. Available: https://youtu.be/H-NDmGHQ9vk.

[4]

M. Cascella, M. Rajnik, A. Aleem, C. S. Dulebohn and R. Di Napoli, "Features, Evaluation, and Treatment of Coronavirus (COVID-19).," in NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health., Treasure Island, StatPearls Publishing, 2022, pp. 1-53.

[5]

G. A. Harrison, T. Lin and P. Wang, "Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.," Trends in Immunology, pp. 1100-1115, 2020.

[6]

A. Gupta, M. Madhavan V and K. Sehgal, "Extrapulmonary manifestations of COVID-19," Nature Medicine, vol. 26, no. 7, pp. 1017-1032, 2020.

[7]

K. McIntosh, M. Hirsch S and A. Blom, "COVID-19: Epidemiology, virology, and prevention," UpToDate, 07 July 2022.

[8]

C. Higgins, "acutecaretesting.org," [Online]. Available: https://acutecaretesting.org/en/journal-scans/d-dimer-testing-in-patients-with-covid-19.

[9]

E. M. D. A. G. O. Sayit AT, "Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia," Rev Inst Med Trop Sao Paulo, 25 June 2021.

[10]

K. Kappert, A. Jahic and R. Tuber, "Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases," Biomarkers, vol. 25, no. 8, pp. 616-625, November 2020.

[11]

G. Lowe Do, A. Pumley and I. Mackie J, "Plasma fibrinogen," in Ann Clin Biochem , 2004, p. 430–440.

[12]

K. Jasmeen and A. Jain, "Fibrinogen," StatPearls [Internet], January 2022.

[13]

J. Sui, N. F. D, S. Gandotra and L. Cao, "Elevated Plasma Fibrinogen Is Associated with Excessive Inflammation and Disease Severity in COVID-19 Patients," fontiers, vol. 11, pp. 1-7, 03 August 2021.

[14]

N. Ali, "Elevated level of C‐reactive protein may be an early marker to," Journal of Medical Virology WILEY, pp. 2409-2411, 2020.

[15]

K. Kappert, A. Jahic and R. Tauber, "Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases," Taylor & Francis Online, vol. 25, no. 8, 2020.

[16]

L. Sukrisman, R. Sinto and D. Priantono, "Hematologic Profiles and Correlation Between Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio with Markers of Inflammation of COVID-19 in an Indonesian National Referral Hospital," Dovepress, vol. 14, pp. 6919-6924, 18 October 2021.

[17]

R. Mardani, M. namavar, E. ghorbi, Z. Shoja, F. Zali, K. Hooman, M. Aghasadeghi Reza, S. Sadeghi Amir, S. Sabeti, I. Darzam Alavi, N. Ahmadi and S. Nasab Mousavi Dawood, "Association between serum inflammatory parameters and the disease severity in COVID-19 patients," Journal of Clinical Laboratory Analysis, vol. 36, no. 1, 2022.

[18]

S. Razu Rahman, Y. T, T. Arif Binte, I. Sh, S. Islam Shariful Mohammed, H. Abrha, Gesesew and P. Ward, "Challenges Faced by Healthcare Professionals During the COVID-19 Pandemic: A Qualitative Inquiry From Bangladesh," frontiers, 10 August 2021.